Tty Biopharm

TTY Biopharm, a Pharmaceutical Preparation Manufacturing company based in TW, reported total carbon emissions of approximately 12,539,339 kg CO2e for 2024. This figure includes Scope 1 emissions of 1,910,257.1 kg CO2e, Scope 2 emissions of 8,116,446.8 kg CO2e, and Scope 3 emissions of 2,512,635.2 kg CO2e.

In 2023, the company's total emissions were approximately 12,738,547.2 kg CO2e, comprising Scope 1 emissions of 1,700,218.1 kg CO2e, Scope 2 emissions of 8,488,804.8 kg CO2e, and Scope 3 emissions of 2,549,524.3 kg CO2e. For 2022, TTY Biopharm reported total emissions of approximately 12,809,742.6 kg CO2e, with Scope 1 at 1,535,316.9 kg CO2e, Scope 2 at 8,232,490.3 kg CO2e, and Scope 3 at 3,041,935.4 kg CO2e.

In 2021, TTY Biopharm's Scope 1 emissions were 925,000 kg CO2e and Scope 2 emissions were 6,975,000 kg CO2e. In 2020, Scope 1 emissions were 953,000 kg CO2e and Scope 2 emissions were 7,740,000 kg CO2e. For 2019, Scope 1 emissions were 977,000 kg CO2e and Scope 2 emissions were 7,236,000 kg CO2e. In 2018, the company reported Scope 1 emissions of 7,780,000 kg CO2e and Scope 2 emissions of 7,780,000 kg CO2e. For 2017, total emissions were 8,264,000 kg CO2e, with Scope 1 at 756,000 kg CO2e and Scope 2 at 4,225,000 kg CO2e. In 2016, Scope 3 emissions from purchased goods and services were 625,000 kg CO2e. For 2015, Scope 1 emissions were 625,000 kg CO2e and Scope 2 emissions were 3,633,000 kg CO2e.

TTY Biopharm has not publicly disclosed any specific quantifiable carbon reduction targets or commitments, nor does it have approved Science Based Targets (SBTi). The company's emissions data is sourced directly from TTY Biopharm Company Limited.